209 related articles for article (PubMed ID: 36125314)
1. Calibrating Hepatitis E Virus Serological Assays Using Asymptomatic Specimens Obtained in Japan.
Terahara K; Li TC; Matsubayashi K; Sakata H; Kato T; Naganuma A; Ogawa K; Honda K; Itakura J; Akutsu N; Tobita H; Korenaga M; Kanto T; Sugiyama R; Suzuki R; Hamaguchi I; Isogawa M; Takahashi Y
Microbiol Spectr; 2022 Oct; 10(5):e0214622. PubMed ID: 36125314
[TBL] [Abstract][Full Text] [Related]
2. Performance Evaluation of Different Commercial Serological Kits for Diagnosis of Acute Hepatitis E Viral Infection.
Zhang Q; Zong X; Li D; Lin J; Li L
Pol J Microbiol; 2020 Sep; 69(2):217-222. PubMed ID: 32548990
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.
Pas SD; Streefkerk RH; Pronk M; de Man RA; Beersma MF; Osterhaus AD; van der Eijk AA
J Clin Virol; 2013 Dec; 58(4):629-34. PubMed ID: 24210958
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of Anti-Hepatitis E Virus Antibody Seroconversion in Asymptomatically Infected Blood Donors: Systematic Comparison of Nine Commercial Anti-HEV IgM and IgG Assays.
Vollmer T; Diekmann J; Eberhardt M; Knabbe C; Dreier J
Viruses; 2016 Aug; 8(8):. PubMed ID: 27556482
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection.
Elkady A; Tanaka Y; Kurbanov F; Hirashima N; Sugiyama M; Khan A; Kato H; Okumura A; Mizokami M
J Gastroenterol; 2007 Nov; 42(11):911-7. PubMed ID: 18008036
[TBL] [Abstract][Full Text] [Related]
6. Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area.
Wu WC; Su CW; Yang JY; Lin SF; Chen JY; Wu JC
J Med Virol; 2014 Apr; 86(4):720-8. PubMed ID: 24395716
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) Is highly specific for diagnosis of acute HEV infection.
Takahashi M; Kusakai S; Mizuo H; Suzuki K; Fujimura K; Masuko K; Sugai Y; Aikawa T; Nishizawa T; Okamoto H
J Clin Microbiol; 2005 Jan; 43(1):49-56. PubMed ID: 15634950
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011.
Vollmer T; Diekmann J; Eberhardt M; Knabbe C; Dreier J
Euro Surveill; 2016 Sep; 21(35):. PubMed ID: 27608433
[TBL] [Abstract][Full Text] [Related]
9. Significance of serum IgA in patients with acute hepatitis E virus infection.
Tian DY; Chen Y; Xia NS
World J Gastroenterol; 2006 Jun; 12(24):3919-23. PubMed ID: 16804983
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of anti-HEV IgA in diagnosis of acute genotype 4 hepatitis E virus infection negative for anti-HEV IgM.
Zhang S; Tian D; Zhang Z; Xiong J; Yuan Q; Ge S; Zhang J; Xia N
Dig Dis Sci; 2009 Nov; 54(11):2512-8. PubMed ID: 19117132
[TBL] [Abstract][Full Text] [Related]
11. [A preliminary study on hepatitis E virus antibody IgG and IgM for the diagnosis of acute hepatitis E].
Li K; Zhuang H; Zhu W; Ruan B; Jiang J; Li S; Zhai Q; Yao Z; Tang R; Chen Y
Zhonghua Nei Ke Za Zhi; 1999 Nov; 38(11):733-6. PubMed ID: 11798711
[TBL] [Abstract][Full Text] [Related]
12. Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus.
Li TC; Zhang J; Shinzawa H; Ishibashi M; Sata M; Mast EE; Kim K; Miyamura T; Takeda N
J Med Virol; 2000 Nov; 62(3):327-33. PubMed ID: 11055242
[TBL] [Abstract][Full Text] [Related]
13. Serological and molecular studies on subclinical hepatitis E virus infection using periodic serum samples obtained from healthy individuals.
Mitsui T; Tsukamoto Y; Suzuki S; Yamazaki C; Masuko K; Tsuda F; Takahashi M; Tsatsralt-Od B; Nishizawa T; Okamoto H
J Med Virol; 2005 Aug; 76(4):526-33. PubMed ID: 15977233
[TBL] [Abstract][Full Text] [Related]
14. Development of an oral fluid immunoassay to assess past and recent hepatitis E virus (HEV) infection.
Pisanic N; Rahman A; Saha SK; Labrique AB; Nelson KE; Granger DA; Granger SW; Detrick B; Heaney CD
J Immunol Methods; 2017 Sep; 448():1-8. PubMed ID: 28478117
[TBL] [Abstract][Full Text] [Related]
15. Disparities in detection of antibodies against hepatitis E virus in US blood donor samples using commercial assays.
Zafrullah M; Zhang X; Tran C; Nguyen M; Kamili S; Purdy MA; Stramer SL
Transfusion; 2018 May; 58(5):1254-1263. PubMed ID: 29520800
[TBL] [Abstract][Full Text] [Related]
16. A nationwide survey of hepatitis E virus infection in the general population of Japan.
Takahashi M; Tamura K; Hoshino Y; Nagashima S; Yazaki Y; Mizuo H; Iwamoto S; Okayama M; Nakamura Y; Kajii E; Okamoto H
J Med Virol; 2010 Feb; 82(2):271-81. PubMed ID: 20029817
[TBL] [Abstract][Full Text] [Related]
17. Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection.
Avellon A; Morago L; Garcia-Galera del Carmen M; Munoz M; Echevarría JM
J Med Virol; 2015 Nov; 87(11):1934-9. PubMed ID: 25959136
[TBL] [Abstract][Full Text] [Related]
18. Detection of hepatitis E virus-specific immunoglobulin a in patients infected with hepatitis E virus genotype 1 or 3.
Herremans M; Duizer E; Jusic E; Koopmans MP
Clin Vaccine Immunol; 2007 Mar; 14(3):276-80. PubMed ID: 17267585
[TBL] [Abstract][Full Text] [Related]
19. Performance evaluation of five commercial assays in assessing seroprevalence of HEV antibodies among blood donors.
Al-Absi ES; Al-Sadeq DW; Younis MH; Yassine HM; Abdalla OM; Mesleh AG; Hadwan TA; Amimo JO; Thalib L; Nasrallah GK
J Med Microbiol; 2018 Sep; 67(9):1302-1309. PubMed ID: 30051802
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E.
Al Absi ES; Al-Sadeq DW; Khalili M; Younes N; Al-Dewik N; Abdelghany SK; Abouzid SS; Al Thani AA; Yassine HM; Coyle PV; Nasrallah GK
BMC Gastroenterol; 2021 Jun; 21(1):266. PubMed ID: 34130641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
